Herpes Zoster Vaccine Slows Biological Aging & May Prevent Dementia

The Unexpected Link Between Vaccines and Healthy Aging: A New Frontier in Longevity

Feb. 1, 2026 at 6:39pm

Got story updates? Submit your updates here. ›

A recent study from the University of Southern California's Leonard Davis School of Gerontology, and further reinforced by research from Stanford University, reveals a surprising connection: the herpes zoster vaccine may actually slow down biological aging. This isn't just about avoiding shingles; it's about potentially adding healthy years to life. The study tracked adults over several years, comparing those vaccinated against shingles to those who weren't, and found that vaccinated individuals exhibited a slower pace of biological aging, even years after receiving the vaccine.

Why it matters

For decades, vaccines have been hailed as protectors against infectious diseases. But this research suggests their benefits extend far beyond simply preventing illness. The key appears to be a reduction in chronic, low-grade inflammation – often dubbed 'inflammaging' – a hallmark of age-related diseases like heart disease, cognitive decline, and frailty. This could mean vaccines may influence the fundamental processes of aging itself, potentially contributing to a healthier lifespan.

The details

The USC study measured biological age across seven key dimensions: inflammation, innate immunity, adaptive immunity, cardiovascular health, neurodegeneration, epigenetic aging, and transcriptomic aging. By combining these indicators into a composite score, researchers gained a comprehensive view of how the shingles vaccine affected the aging process. The link between vaccination and long-term health was further strengthened by a study conducted in Wales, which found that adults who received the shingles vaccine experienced a 20% reduction in the risk of developing dementia over a seven-year follow-up period.

  • The USC study was published in the Journals of Gerontology, Series A.
  • The Wales study was published in Cell.

The players

Jung Ki Kim

Associate professor of research gerontology and lead author of the USC study.

Dr. Pascal Geldsetzer

Researcher at Stanford Medicine who worked on the Wales study.

University of Southern California's Leonard Davis School of Gerontology

The institution that conducted the study on the connection between the herpes zoster vaccine and biological aging.

Stanford University

The institution that further reinforced the research on the link between the herpes zoster vaccine and biological aging.

Got photos? Submit your photos here. ›

What they’re saying

“We're starting to see evidence that vaccines can do more than just protect against specific diseases. They may influence the fundamental processes of aging itself, potentially contributing to a healthier lifespan.”

— Jung Ki Kim, Associate professor of research gerontology (Journals of Gerontology, Series A)

“The signal in our data was so strong, so clear, and so persistent.”

— Dr. Pascal Geldsetzer (Cell)

What’s next

Researchers are increasingly focused on measuring biological age to understand the true impact of interventions like vaccination. Beyond shingles and influenza, researchers are investigating the potential benefits of vaccines against other age-related conditions, including pneumonia and even Alzheimer's disease. As we learn more about individual immune responses, we may see personalized vaccination schedules tailored to optimize healthspan.

The takeaway

These findings are sparking a wave of new research exploring the potential of vaccines to promote healthy aging. The focus is shifting from vaccines solely as disease preventatives to vaccines as tools to modulate the immune system and reduce chronic inflammation, which is a key driver of age-related diseases. Increasing awareness of the potential benefits of vaccination beyond disease prevention is crucial.